[Experience with a preparation with a structural neurophospholipid base in infantile neuropsychiatry].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D001921:Brain / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008607:Intellectual Disability / Q000188:drug therapy*; D007859:Learning Disabilities / Q000188:drug therapy*; D050356:Lipid Metabolism; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D010743:Phospholipids / Q000378:metabolism / Q000627:therapeutic use*; D011506:Proteins / Q000378:metabolism
D000305:Adrenal Cortex Hormones; D010743:Phospholipids; D011506:Proteins
Esperienze con un preparato a base di neurofosfolipidi strutturali in neuropsichiatria infantile.